Published in
Elsevier, Journal of Allergy and Clinical Immunology, 6(138), p. 1752-1755
DOI: 10.1016/j.jaci.2016.07.015
Links
Tools
Efficacy of the Janus kinase 1/2 inhibitor ruxolitinib in the treatment of vasculopathy associated with TMEM173 -activating mutations in 3 children
Journal article published in 2016 by
Marie-Louise Frémond,
Mathieu Paul Rodero,
Nadia Jeremiah,
Alexandre Belot,
Eric Jeziorski 
,
Darragh Duffy,
Didier Bessis,
Guilhem Cros,
Gillian I. Rice,
Bruno Charbit ,
Anne Hulin,
Nihel Khoudour,
Consuelo Modesto Caballero,
Christine Bodemer,
Monique Fabre
and other authors.
,
Darragh Duffy,
Didier Bessis,
Guilhem Cros,
Gillian I. Rice,
Bruno Charbit ,
Anne Hulin,
Nihel Khoudour,
Consuelo Modesto Caballero,
Christine Bodemer,
Monique Fabre
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Postprint:
archiving forbidden
Published version:
archiving forbidden
Data provided by 